Furosemide

CAS 54-31-9 11 current records 13 historicalSmall Molecule

Who holds supplier records for Furosemide? 11 organisations hold a current record for Furosemide: an active US FDA Type II Drug Master File or a CEP. A further 13 organisations have only historical (inactive) DMF filings. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (8), Germany (1), Italy (1) and Netherlands (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Furosemide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/furosemide

Reading the evidence

  • 11 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    8 of the 11 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Furosemide expires 10 Jan 2042. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (11)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Furosemide. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Furosemide sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (8)

Certificates of Suitability on the EDQM register for Furosemide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 11 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
SRI KRISHNA PHARMACEUTICALS LIMITED HyderabadIN
CEP 2013-273 - Rev 01
Furosemide, Alternative process
Dec 2025—
HEM-DEEP ORGANICS PRIVATE LIMITED AnkleshwarIN
CEP 2023-331 - Rev 00
Furosemide
Aug 2025—
TAPI NL B.V. AmsterdamNL
CEP 1997-019 - Rev 10
Furosemide
Jul 2025—
MANGALAM DRUGS & ORGANICS LTD. MumbaiIN
CEP 2019-063 - Rev 02
Furosemide
Apr 2025—
EUROAPI GERMANY GmbH Frankfurt am MainDE
R1-CEP 2005-274 - Rev 03
Furosemide
Dec 2021—
CURIA INDIA PRIVATE LIMITED HyderabadIN
R1-CEP 1999-069 - Rev 09
Furosemide
Aug 2021—
IPCA Laboratories Limited MumbaiIN
R1-CEP 1998-020 - Rev 07
Furosemide
Oct 2019—
F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. Montecchio MaggioreIT
R1-CEP 2004-005 - Rev 03
Furosemide
Feb 2014—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (13)

Organisations whose Type II DMFs for Furosemide are no longer active. These show a past filing, not current supply.

Show all 13 historical records
  • Italy · Inactive DMF 19975 · filed Nov 2006
  • Italy · Inactive DMF 12896 · filed Mar 1998
  • INTERMEDI CHIMICI SINTETICI SPA ZONA INDUSTRIALE
    Inactive DMF 6323 · filed Feb 1986
  • SALSBURY CHEMICALS INC
    Inactive DMF 5993 · filed Aug 1985
  • SELOC AG
    Inactive DMF 5547 · filed Oct 1984
  • ORION CORP FARMOS CHEMICAL PLANT
    Inactive DMF 3435 · filed Jan 1979
  • CHINOIN PHARMACEUTCIAL AND CHEMICAL WORKS CO LTD
    Inactive DMF 3331 · filed Oct 1978
  • DINAMITE DIPHARMA SPA
    Inactive DMF 3364 · filed Aug 1978
  • SCHARPER SPA
    Inactive DMF 3265 · filed Apr 1978
  • CIECH POLFA
    Inactive DMF 3134 · filed Jan 1978
  • PLANTEX LTD CHEMICAL AND PHARMACEUTICAL WORKS
    Inactive DMF 3033 · filed Sept 1977
  • SOLMAG SPA
    Inactive DMF 2649 · filed Apr 1976
  • HOECHST CELANESE CORP
    Inactive DMF 1834 · filed Nov 1971

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (46 listed products contain Furosemide). The latest listed patent expires 10 Jan 2042. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Furosemide is a high-ceiling diuretic of the class of sulfonamide loop diuretics, used primarily to treat fluid build-up due to heart failure, liver scarring, or kidney disease. It functions by inhibiting the sodium-potassium-chloride cotransporter in the thick ascending limb of the loop of Henle, thereby increasing the excretion of sodium, water, and other ions.

Chemical identity

IUPAC name
4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid
Canonical SMILES
C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
InChIKey
ZZUFCTLCJUWOSV-UHFFFAOYSA-N
Synonyms
Lasix API, frusemide, furoscix, furosemidum, lasix, lasix onyu, lb-502, logirene, marsemide, mirfat, nsc-269420, oedemex

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Loop Diuretic
Physiologic effect
Increased Diuresis at Loop of Henle

Therapeutic areas

CardiovascularRenalFluid Retention

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Furosemide?

11 organisations hold an active US FDA Type II Drug Master File or a CEP for Furosemide: CURIA INDIA PRIVATE LIMITED (India), EUROAPI GERMANY GMBH (Germany), FIS FABBRICA ITALIANA SINTETICI SPA (Italy), Ipca Laboratories Limited (India), SRI KRISHNA PHARMACEUTICALS LTD (India), TAPI NL BV (Netherlands), Ambition Pharma Ltd. (India) and HALEOS LABS LTD (India), and 3 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Furosemide Drug Master Files are active?

CURIA INDIA PRIVATE LIMITED (DMF 30288), EUROAPI GERMANY GMBH (DMF 11785), FIS FABBRICA ITALIANA SINTETICI SPA (DMF 3513), Ipca Laboratories Limited (DMF 10109), SRI KRISHNA PHARMACEUTICALS LTD (DMF 23396), TAPI NL BV (DMF 2565), Ambition Pharma Ltd. (DMF 43709) and HALEOS LABS LTD (DMF 39960) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Furosemide records mean?

13 organisations have only inactive Type II DMFs for Furosemide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Furosemide have a European Certificate of Suitability?

Yes. 8 organisations hold a valid CEP for Furosemide on the EDQM register, including SRI KRISHNA PHARMACEUTICALS LIMITED Hyderabad (IN), HEM-DEEP ORGANICS PRIVATE LIMITED Ankleshwar (IN), TAPI NL B.V. Amsterdam (NL), MANGALAM DRUGS & ORGANICS LTD. Mumbai (IN), EUROAPI GERMANY GmbH Frankfurt am Main (DE) and CURIA INDIA PRIVATE LIMITED Hyderabad (IN) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Furosemide?

Yes. The latest patent listed for an approved US product containing Furosemide expires 10 Jan 2042, across 46 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Furosemide supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Furosemide?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.